Novavax Co. (Nasdaq: NVAX) tau xa ib tsab ntawv ceeb toom rau Gavi, Lub Koom Haum Tshuaj Tiv Thaiv, txiav tawm nrog kev pom zoo tam sim ntawd rau kev muag nws cov tshuaj tiv thaiv COVID-19 rau cov teb chaws tau nyiaj tsawg thiab nruab nrab.
Lub tuam txhab tau hais txog Gavi qhov tsis ua tiav ntawm 350 lab koob tshuaj uas nws tau pom zoo yuav hauv lub Tsib Hlis xyoo tas los rau lub chaw COVAX.
Qhov kev txiav tawm tsis tau ua rau muaj kev nplua, lub tuam txhab hais tias nyob rau hauv nws cov ntaub ntawv tswj.
Related: Canada pom zoo Novavax's COVID-19 Vaccine Raws li Booster Hauv Cov Neeg Laus.
Novavax tau txais cov nyiaj them ua ntej uas tsis tuaj yeem thim rov qab ntawm $ 350 lab los ntawm Gavi xyoo tas los thiab ntxiv $ 350 lab xyoo no tom qab txhaj tshuaj tiv thaiv WHO. cov npe siv thaum muaj xwm ceev, lub tuam txhab hais tias.
Raws li lub Kaum Ib Hlis 18, lub tuam txhab tsuas tau txais kev txiav txim raws li kev pom zoo rau kwv yees li 2 lab koob tshuaj.
Cov lus tshaj tawm los tom qab ntawm kev thov tsis zoo rau lub tuam txhab txhaj tshuaj thaum lub ntiaj teb cov khoom noj khoom haus tsis txaus rau cov tshuaj tiv thaiv COVID-19 thiab kev thov poob qis.
Nyuam qhuav pib lub hlis no, lub tuam txhab tau hloov kho nws FY22 kev muag khoom kwv yees rau lub sijhawm thib ob ntawm qhov kev thov tsis txaus rau cov tshuaj tiv thaiv COVID-19.
Lub tuam txhab tam sim no cia siab tias cov nyiaj tau los txhua xyoo yuav yog kwv yees li $ 2.0 nphom, qhov kawg ntawm nws qhov qis Kev kwv yees ua ntej ntawm $ 2 billion - $ 2.3 billion.
Nqe Nqis: NVAX shares tau nce 0.63% ntawm $ 19.07 premarket ntawm daim tshev kawg hnub Tuesday.
Saib ntxiv ntawm Benzinga
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/novavax-terminates-agreement-gavi-alliance-131127211.html